4//SEC Filing
Rothera Mark 4
Accession 0001209191-22-050628
CIK 0001061027other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 7:04 PM ET
Size
6.0 KB
Accession
0001209191-22-050628
Insider Transaction Report
Form 4
Rothera Mark
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-09-19+1,375,000→ 1,375,000 totalExercise: $5.21Exp: 2032-09-19→ Common Stock (1,375,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total shares subject to the Option will vest on the one (1)-year anniversary of the grant date and 1/48th of the total shares subject to the Option will vest each month thereafter on the same day of the month as the grant date (and if there is no corresponding day, the last day of the month), subject to the Reporting Person continuing to be a Service Provider in accordance with the Company's 2021 Inducement Equity Incentive Plan through each such date.
Documents
Issuer
Viracta Therapeutics, Inc.
CIK 0001061027
Entity typeother
Related Parties
1- filerCIK 0001550424
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 7:04 PM ET
- Size
- 6.0 KB